Mary Norine Walsh, MD, immediate past president of the American College of Cardiology, discusses the cause of the recent increase in maternal mortality, and the importance of team-based care to address it.
Transcript:
The United States has seen an increase in maternal deaths. Some attribute this to better reporting, others say it indicates a rise in comorbidities and a lack of equal access to care. Can better approaches to team-based care close these gaps?
Well, the rise in maternal mortality is really concerning because we don't see this worldwide. In fact, maternal mortality is declining worldwide, but not in the United States. I do think it's multifactorial— we certainly cannot simply say that we're counting patients more accurately than we did in the past, that's absolutely not the sole issue that we're dealing with.
The age of first birth has risen in the United States year on year recently. With that we do see an increase in comorbid conditions such as high blood pressure, diabetes, even coronary artery disease and valvular disease. Assessing women in advance of pregnancy, if possible, is very important. But the thing we really need to focus on is a team— a cardio-obstetric team that if a woman does develop hypertension, preeclampsia, signs and symptoms during pregnancy, or soon after delivery. We have to have a team in place that is knowledgeable about these diseases and conditions in pregnant and postpartum women so that we can rapidly take care of a patient as a team.
That team would involve maternal fetal medicine physicians, nurses, OB/GYN's, cardiologists, midwives, nurse practitioners, the whole team working together to make sure that the woman is cared for very well.
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Ways Providers, Payers Can Ensure Biomarker Testing Is Done in Cancer Care
October 18th 2024There is a role for both payers and providers to make small changes that would increase the use of biomarker testing to ensure patients are receiving the appropriate treatment, said Susan Wescott, RPh, MBA, senior director of managed care pharmacy, Mayo Clinic.
Read More